stocks

Stock Market Today: Another Vaccine-Trial Stumble Clips Wall Street's Optimism

Johnson & Johnson (JNJ) paused a vaccine study, and Eli Lilly (LLY) was forced to do the same on a treatment trial, hampering stocks Tuesday.

Investors had plenty to chew on Tuesday, and it showed in a down day for stocks.

The big headline out of the gate was Johnson & Johnson (JNJ, -2.3%) pausing late-stage trials for its promising COVID-19 vaccine due to an "unexplained illness," which, as we explained when AstraZeneca (AZN) was forced to do the same, isn't uncommon and doesn't necessarily spell doom for the treatment.

"JNJ decided to temporarily halt all dosing of the Covid-19 vaccine candidate due to an unexplained illness in a volunteer in the study," writes CFRA's Sel Hardy, who nonetheless maintained a Strong Buy rating on JNJ and upgraded earnings estimates after the company's strong third-quarter earnings results. "We welcome JNJ's transparency and expect to see further clarity as the issue is examined by an independent board."

Meanwhile, stimulus talks remained muddy; Senate Majority Leader Mitch McConnell said his chamber would vote on a bill centered around the Paycheck Protection Program (PPP) sometime this month, though it's uncertain whether it would get past the House.

Apple (AAPL, -2.7%) gave up a little of its recent gains after it unveiled a suite of four new iPhones, including an iPhone 12 Mini with a 5.4-inch screen. And JPMorgan Chase (JPM, -1.6%), which kicked off the Q3 earnings calendar by beating expectations, still slumped as CEO Jamie Dimon warned more stimulus is needed to help the economy.

The Dow Jones Industrial Average slipped 0.6% to 28,679.

Other action in the stock market today:

  • The Nasdaq Composite managed a mere 0.1% decline to 11,863.
  • The S&P 500 fell 0.6% to 3,511.
  • The small-cap Russell 2000 lost 0.7% to 1,636.

COVID Treatments' Push and Pull on Wall Street

The broader market results don't indicate much fallout from today's disappointing COVID-19 news, which also included a halt to Eli Lilly's (LLY, -2.9%) antibody treatment.

But take a closer look: Industrials, real estate, banks and energy, which rely heavily on robust economic activity, were solidly lower today. However, technology and communications once again showed relative strength as they have all year, bolstering the fortunes of technology funds such as these 15 products, and that should continue to be the case as long as effective treatments and vaccines remain elusive.

The same goes for the Invesco QQQ Trust (QQQ), which invests in the index composed of the Nasdaq's 100 largest financials and has raked in billions in assets this year, prompting Invesco to launch even more funds tied to the index. (You can read about a host of Nasdaq-100 products here.)

At some point, however, a vaccine or treatment will finally get the green light, and while it might take months to reach most of America's population, most experts expect that to "flip the switch" for a host of battered industries. Here, we look at 11 stocks to buy that are in rough shape right now, but that could pivot in a heartbeat when a game-changing medical breakthrough is announced.

Kyle Woodley was long AAPL and QQQ as of this writing.

Most Popular

11 Good Reasons to Cancel Amazon Prime
Budgeting

11 Good Reasons to Cancel Amazon Prime

You probably aren't using most of the perks tucked into that $119 annual fee -- which you don't need to pay to get the free Amazon shipping you crave.
April 13, 2021
2021 Child Tax Credit Calculator
Tax Breaks

2021 Child Tax Credit Calculator

See how much money you'll get in advance under the new child tax credit rules for 2021.
April 14, 2021
Monthly Payments of the 2021 Child Tax Credit Will Begin in July
Coronavirus and Your Money

Monthly Payments of the 2021 Child Tax Credit Will Begin in July

After doubts about whether it was up to the task, the IRS says it's on schedule to start sending monthly child tax credit payments this summer.
April 13, 2021

Recommended

Stock Market Today 4/15/21: Dow Clears 34K, Nasdaq Tops 14K as Recovery Accelerates
Stock Market Today

Stock Market Today 4/15/21: Dow Clears 34K, Nasdaq Tops 14K as Recovery Accelerates

A steep decline in unemployment claims and better-than-expected retail sales provided fresh evidence of an economic recovery and triggered a broad ral…
April 15, 2021
Stock Market Today 4/14/21: Strong Start to Earnings Season Sends Dow Higher
Stock Market Today

Stock Market Today 4/14/21: Strong Start to Earnings Season Sends Dow Higher

Goldman Sachs' (GS) record Q1 and a strong day for Chevron (CVX) helped keep the Dow in positive territory on an otherwise choppy Wednesday.
April 14, 2021
Buy Cruise Line Stocks? The Pros Aren't So Sure
stocks

Buy Cruise Line Stocks? The Pros Aren't So Sure

Cruise line stocks have performed well so far in 2021, but analysts are still sitting on the sidelines amid cloudy reopening plans. 
April 14, 2021
Stock Market Today 4/13/21: Nasdaq Climbs, Dow Slips After J&J Vaccine Stumble 
Stock Market Today

Stock Market Today 4/13/21: Nasdaq Climbs, Dow Slips After J&J Vaccine Stumble 

U.S. agencies recommended a pause in use of the Johnson & Johnson COVID vaccine amid rare instances of a blood clotting disorder, rattling the recover…
April 13, 2021